Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
cross-contamination
Pharma
GSK amends deal with Scynexis amid Brexafemme manufacturing woes
GSK has downgraded a licensing deal for Scynexis' antifungal ibrexafungerp following an ongoing recall of the drug's approved form, Brexafemme.
Fraiser Kansteiner
Jan 3, 2024 11:44am
Fresenius pulls hospital sedative again for lidocaine mixup
Nov 20, 2020 8:15am
Sun and Lupin pulled clonazepam and lisinopril lots in the U.S.
Aug 10, 2020 11:30am
Honeywell pivots its patented plastic tech to make drug vials
Jul 29, 2020 10:39am
FDA hits Cipla with warning letter for sterile injectables plant
Mar 18, 2020 2:47pm
FDA orders Cadila to clean up its act at sterile plant in India
Nov 13, 2019 3:00pm
